MRP3 expression is associated with menopausal status, tumor size, histology, clinical stages, lymph node metastasis status, PR status, HER2 status, p53 status, and BRCA2 status (P < 0.05), but not with other clinical pathological parameters. Here, PGR is linked to metastatic malignant neoplasm in the lymph nodes.